Global Cord Blood (CO) Growth Rates Comparisons to Healthcare Facilities Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Global Cord Blood Corp  (NYSE: CO)
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

Global Cord Blood Growth Comparisons

Select each growth Category to receive further Information





CO Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) 10.8 % 8.82 % 14.64 % 14.5 %
Q / Q Revenue Growth (Q1 MRQ) - 8.05 % 0.69 % -1.48 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -13.02 % 15.49 % 22.94 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) - 1.6 % 3.22 % 3 %
Revenue 5 Year Average Growth 12.18 % 2.44 % 11.14 % 9.81 %


CO's Growth Comparisons in IV. Quarter 2022




Global Cord Blood improved it's Revenue by 10.8% year on year in the fourth quarter 2022, and outpaced the 8.82% growth in the Healthcare Facilities industry, but Global Cord Blood's growth compares unfavorably, to the 14.64% Revenue improvement in the Healthcare sector.

Sequentially company's Revenue were unchanged from the third quarter results. . Looking into annual growth, sales grew by 12.18% on average in last five years, while S & P 500's including only Businesses with the fourth quarter 2022 earnings reports, average yearly sales growth is 9.81%.


Growth Rates of CO's Income in the fourth quarter 2022


CO Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) 15.49 % -72.86 % 4.03 % 14.73 %
Sequential Operating Income Change (Q1 MRQ) - -82.39 % -6.41 % -12.7 %
Y / Y Operating Income Growth (Q1 TTM) -11.12 % 12.91 % 60.84 % 59.76 %
Sequential Operating Income Growth (Q1 TTM) 15.49 % -16.33 % 2.47 % 2.49 %
Operating Income 5 Year Avg. Change 20.07 % -3.17 % 7.75 % 9.37 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) 2.01 % - -30.86 % 12.59 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - - -29.83 % 3.2 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) 2.01 % -14.56 % 72.59 % 63.82 %
Sequential Income from Cont. Ops. Change (Q1 TTM) 2.01 % -48.46 % -5.75 % 0.34 %
Income from Cont. Ops. 5 Year Avg. Change 33.87 % - 14.27 % 10.57 %

CO Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) 2.01 % - -31.41 % 13.8 %
Q / Q Net Income Growth (Q1 MRQ) - - -33.8 % 3.68 %
Y / Y Net Income Change (Q1 TTM) -18.55 % 10.04 % 76.53 % 67.8 %
Sequential Net Income Change (Q1 TTM) 2.01 % -48.34 % -5.76 % 0.66 %
Net Income 5 Year Avg. Growth 33.87 % - 17.81 % 3.27 %

CO's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) 1.56 % - -30.86 % 12.59 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - - -29.83 % 3.2 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) -61.08 % - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) 1.56 % -86.23 % - 6640.43 %
EPS from Cont. Ops. 5 Year Avg. Growth 20.98 % - 14.27 % 10.57 %



CO EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) 1.56 % - -31.41 % 10.57 %
Q / Q EPS Net Growth (Q1 MRQ) - - -33.8 % 3.68 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 40036.37 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) 1.56 % -87.07 % - 55.38 %
EPS Net 5 Year Avg. Change 20.98 % - 17.81 % 3.27 %



Comparing 1.56% year on year bottom-line growth in the fourth quarter, Global Cord Blood grew on the lower pace than the 8.82% growth in the Healthcare Facilities industry, but beating the -31.41% cut in the Healthcare sector. Slow fourth quarter 2022 income per share, in Healthcare Facilities industry and Healthcare sector, were portrayed in Global Cord Blood Corp results which underperformed overall market.

Sequentially company's EPS were unchanged from the third quarter results. . Looking into annual growth, income per share grew by 20.98% on average in the last five years, while the S & P 500's including only the businesses with the fourth quarter 2022 financial results, average yearly income per share growth is 3.27%.

CO Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) 9.89 % -63.62 % -24.93 % -0.56 %
Sequential Free Cash Flow Change (Q1 MRQ) - -85.13 % -37.68 % -42.06 %
Y / Y Free Cash Flow Change (Q1 TTM) 9.89 % -53.33 % 10.74 % 35.72 %
Sequential Free Cash Flow Change (Q1 TTM) 9.89 % 103.2 % -0.09 % -3.7 %
Free Cash Flow 5 Year Avg. Change 0.75 % 6.69 % 14.15 % -25.16 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) 36.92 % - - -
Sequential Net Cash Flow Change (Q1 MRQ) - - - -
Y / Y Net Cash Flow Change (Q1 TTM) 36.92 % - - -85.17 %
Sequential Net Cash Flow Change (Q1 TTM) - - - -60.83 %
Net Cash Flow 5 Year Avg. Change 4.83 % - -3.88 % 31.88 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) -6.84 % 17.72 % 13.19 % 11.66 %
Sequential Capital Expenditures Change (Q1 MRQ) - -45.29 % -29.51 % -22.93 %
Y / Y Capital Expenditures Change (Q1 TTM) -6.84 % 20.44 % 11.5 % 20.71 %
Sequential Capital Expenditures Change (Q1 TTM) -6.84 % 1.9 % 1.75 % 2.76 %
Capital Expenditures 5 Year Avg. Change - 6.02 % 9.46 % 8.19 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.